CHEO Research Institute Logo
Decrease Text SizeIncrease Text SizeFacebookTwitterYoutube

researchers working in a lab

Erick Sell
Investigator, CHEO Research Institute
Physician, Division of Neurology, CHEO
Assistant Professor, Department of Medicine,
Faculty of Medicine, University of Ottawa
613-737-7600 Ext. 3467
Research Practice Areas:
  • Angelman Syndrome
  • Epilepsy
  • NeuroRare
Current Research:
Dr. Sell is interested in Angelman Syndrome. The objective is to improve the quality of life for patients and families with Angelman syndrome. We are running a Angelman syndrome clinic with patients coming from different places in Ontario. We want to build a database for all patients with Angelman syndrome in Canada.
Research Team:
Dr. Sell is a Clinical-Teacher at CHEO, and as Assistant Professor in the Department of Medicine at the University of Ottawa. He is a specialist pediatric Neurology and Epilepsy where he is published in the areas of rare genetic forms of refractory epilepsy and epilepsy therapeutics.
Sample Publications:
Vanstone JR, Smith AM, McBride S, Naas T, Holcik M, Antoun G, Harper ME, Michaud J, Sell E, Chakraborty P, Tetreault M; Care4Rare Consortium, Majewski J, Baird S, Boycott KM, Dyment DA, MacKenzie A, Lines MA. "DNM1L-related mitochondrial fission defect presenting as refractory epilepsy." Eur J Hum Genet. 2015 Nov 25
Dyment D, Sell E, Vanstone M, Smith A, Garandeau D, Garcia V, Carpentier S, Le Trionnaire E, Sabourdy F, Beaulieu C, Schwartsentruber J, McMillan H, FORGE Canada Consortium, Majewski J, Bulman D, Levade T, Boycott K. "Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy." Clin Genet. 2013 Oct 25  
Take Action
Quick Links

Our Researchmagnifying glass

abcefg hijklmnopqrst uvwxyz